APG Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
APG Asset Management's CRL Position: Q2 2025 in Review
APG Asset Management sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 27,300 shares — an estimated $3.8M sold.
APG Asset Management first reported a position in CRL in Q3 2017 and held it in 20 quarters. The position peaked at $33.6M in Q4 2017. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.
- APG Asset Management reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
- APG Asset Management sold 27,300 Charles River Laboratories shares in Q2 2025, an estimated $3.8M.
- APG Asset Management first reported a position in Charles River Laboratories in Q3 2017 and held it in 20 quarters.
- APG Asset Management's Charles River Laboratories position peaked at $33.6M in Q4 2017.
- 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.
Based on APG Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.